prakash7793
5+ Views

How COVID-19 Impacted on Emergency Medical Transportation in Healthcare Industry ?

The global outbreak of SARS-CoV-2 virus has led to a major public health problem due to the emergence of COVID-19 pandemic. The impact of pandemic on healthcare services has been straining and governments as well as players in healthcare industry are monitoring demand types and volumes to anticipate future resource needs. The pandemic has led to a rise in demand for emergency transportation for medical services, however, in numerous cases the demand has been affected due to public apprehension for fear of infection regarding involvement with the health system.
The demand for emergency transportation is especially driven by customized transport vehicles offering emergency care services to COVID-19 patients such as inclusion of emergency transport ventilators. Several notable emergency transport manufacturers and providers have integrated advanced technologies and equipment in order to cope with the mounting emergency services demand. As a response to COVID-19, numerous players in the market are getting involved in strategic agreements and collaborations with companies in all parts of the value chain.
For instance,
· BS6-compliant Supro developed by Mahindra is equipped with beacon light, 75 percent frosted windows, and AIS 125- certified retro-reflective decals. Similarly, many companies are involved in introducing enhanced products along with simultaneously boosting production to capture larger market share.
COVID-19 pandemic has significantly driven the market for emergency medical transport across the world. The persistence of the COVID-19 for a prolonged period has driven the demand for emergency medical transportation.
Throughout the pandemic, the use of ambulances has risen. The demand for EMS (emergency medical service) such as medical transport for "time-sensitive diseases" such as heart conditions, strokes, and acute abdominal diseases among others has also increased. Increasing number of COVID-19 patients across globe has boosted the demand for emergency medical transportation and is anticipated to drive the market growth during the forecast period.
Increasing patient suffering from chronic diseases is a key factor driving the demand for emergency medical transportation services in the globe market, throughout the analysis period. Additionally, the growth in road accidents is also creating a need for ambulance or emergency services.
IMPACT ON PRICE
Emergency medical transportation (EMS) and acute medical service that insurance companies include in plans are affected due to the pandemic. For senior population the acute medical service offered by EMS transportation is available for hospitalization. These factors have increased the cost of ambulatory services. COVID-19 has impacted the emergency medical services due to surge in prices for emergency medical services.
EMS transportation is incentivized by major insurances across globe. However, the cost of emergency medical transportation has increased during the pandemic due to requirement of additional personal protective equipment, staff shortages, increasing cleaning and sanitization cost, and decreased reimbursement.
IMPACT ON DEMAND
The sudden rise of the COVID-19 pandemic enforced an optimistic impact on the global emergency medical transportation market growth in 2020. Rising demand for emergency medical transport for offering emergency care services for COVID-19 patients during the pandemic is driving the growth of the market. During COVID-19 pandemic, key ambulance service providers and equipment & vehicle manufacturers have incorporated various advanced technologies as well as boosted the production to deal with the increasing demand for emergency medical transportation and equipment.
The unprecedented outbreak of COVID-19 has positively affected the demand for emergency medical transportation. In order to prevent the outbreak, NGOs, charity institutions, semi-governmental & governmental bodies are all focusing on deployment of emergency transportation. There are numerous startups that emerged to cope up with the high demand for emergency transportation.
For instance,
· A startup called eSahai based in Hyderabad experienced heightened operations amid the pandemic outbreak with requests via mobile apps and call centers. The emerging services are especially in high demand for worst affected countries that lack necessary healthcare related resources.
The emergency services had an asset utilization issue where occupancy rate was very low. Most hospital emergency transportations are often stretched thin while private transports are under-utilized due to their lack of standards. The private transport owners’ lack of medical know-how has affected the quality of transport provided. The precaution and quality are especially relevant in cases of COVID-19 patients where the risk of infection is very high due to the contagious nature of the virus. The lower quality of the transportations has led to an increased and enhanced supply from budding startups and service businesses.
For instance,
· StanPlus, an emergency transportation service served 10 times demand in 2021, where over 70% of the requests were COVID-19.
In response to the surge in demand for this equipment, vendors are raising funds and developing platforms and tools that meet the needs for COVID-19 surveillance and treatment. For instance,
· The American Ambulance Association recently begged the Department of Health and Human Services for USD 2.6 billion in emergency funding.
Emergency medical transportation such as ambulance providers are hostile to meet rising demand even though the cost has increased due to personal protective equipment, staff shortages, as well as decreased reimbursement.
IMPACT ON SUPPLY CHAIN
The government imposed total lockdown which led to supply chain disruptions. Consequently, the supply chain came to standstill due to the closure of borders. Even though the demand for ambulance and equipment use in emergency ambulance was high, the availability was affected due to disruptions in the supply chain, trade, and travel restrictions. Supply of raw material was also affected, due to which the production was restricted. Bottlenecks in the supply were foreseen due to limited production. Still, some companies managed to overcome the challenges and saw high growth.
Government has also taken initiatives to regularize the supply of equipment uses in ambulance and emergency medical vehicles. So there is limited effect of COVID-19 on supply chain on the emergency medical transportation market.
The supply chain and logistic disruption of equipment use in emergency medical transportation and disruption in ambulance manufacturing has hampered the market for initial phase of pandemic however this equipment are considered under essential medical devices, due to which it’s supply is regularized during the pandemic situation.
STRATEGIC DECISIONS BY SERVICE PROVIDER AND PRODUCT MANUFACTURER
As the reality of COVID-19 dawned upon the world, the service provider, manufacturers and production units of companies involved in emergency medical transportation formed strategies to deal with the limitation that occurred due to coronavirus and keep their business running.
For instance,
All providers had developed special procedures and safety instructions in preparation for COVID-19. Ground ambulance transport was the preferred mode of emergency medical transport in primary missions, whereas air ambulance transport was preferred for interfaculty emergency medical transport.
Several manufacturers are following similar strategic patterns and procedures to gain an edge on decisions taken regarding production as well as sales.
Several manufacturers of emergency medical transportation market also coming forward to help each other in terms of finance as well as other market parameters to not only save the market scenario but to save themselves from the brutal grasp of the pandemic.
CONCLUSION
Pandemic has taken a toll on every aspect of life, including the global economy. With the significant downfalls in many sectors, a collaborative effort of government, industry players, and consumers can win the fight against COVID-19.
It still continues to inflict the world with appalling economic and social dilemmas, capable enough to leave severe backlash on the economy for the next several years. The first wave had already inflicted severe blows to the population as well as the economy. The currently experiencing second wave is expected to be more disastrous not only to the masses but also to food and beverages markets.
Moreover, key companies and government bodies are exclusively concentrating on how they can make the effective and best contribution to control the spread of the virus and save lives. Key companies are dealing with the suddenly increasing demand for emergency medical transportation services by implementing various strategies to overcome current problem and to fulfil the rising demand for emergency medical transportation.
COVID-19 has impacted each sector with no exception. The emergency medical transportation market has been affected the same. With rising number of COVID-19 patients led to increased demand for emergency medical transportation. Global emergency medical transportation market is experiencing a boost due to the ongoing COVID-19 Pandemic due to the above given factors. Global emergency medical transportation market is experiencing a boost due to the ongoing COVID-19 pandemic.
Comment
Suggested
Recent
Cards you may also be interested in
How COVID-19 Impacted on Oral Care in Healthcare Industry ?
COVID-19 Impact on Oral Care in Healthcare Industry OVERVIEW The COVID-19 pandemic has posed a complex challenge in front of several healthcare companies and proved to be an unprecedented global health threat. This global pandemic has emerged in December 2019 which has been proved as a global pandemic by WHO in March 2020. With the development and introduction of novel coronavirus vaccine, COVID-19 cases have been declined but with the development of mutant coronavirus strain, the overall COVID-19 cases have been surged and are increasing at a rapid rate in India, and the U.K, and other European countries. The most common symptoms associated with this include cough, fever, diarrhea, sore throat, and loss of smell or taste. Patients affected with COVID-19 are at increased risk of developing hepatic manifestations and also experiences damage to liver tissues. COVID-19 has led to the closure and reduced hours of dental practices except for emergency and urgent services, limiting routine care and prevention. Dental care includes aerosol-generating procedures that can increase viral transmission. The pandemic offers an opportunity for the dental profession to shift more toward non-aerosolizing, prevention-centric approaches to care and away from surgical interventions. Direct effects of COVID-19 on oral health include ageusia (an official symptom of COVID-19) and case reports of vesiculobullous lesions and necrotizing periodontal disease. oral care product has a wide portfolio such as breath Fresheners, Mouth Wash, Dental Floss, among other products. The Article here shows the impact of COVID-19 on the oral care market. IMPACT ON PRICE As the mouth is an important place for bacterial colonization due to which it is necessary to use the product for oral hygiene. With the sudden increase in COVID-19 cases, people's concerns for better health had also increased and the link between oral health and COVID-19 infection also expand the health to oral. As India relies on China for 70% of API’s intermediates and bulk ingredients, COVID -19 is expected to hike the price of the ingredient used for an oral care product For instance, · In the year 2021, As Proctor & Gamble announced the third-quarter result in which the net sales increase by 5 %, and also mentioned that they are planning for a price hike in certain product divisions. This step is taken seeking to recover the revenue loss during COVID-19. · According to GlaxoSmithKline plc, the cost of dental consultation and treatment was cited as the concerning factor IMPACT ON DEMAND The coronavirus has affected the various regions of the world and caused the widespread closure of companies and local manufacturing plants. This lockdown and isolation have adversely impacted global economic activity. As studies around the world have shown the improving oral hygiene is expected to increase the chance of generating demand for the product. THE IMPACT OF COVID-19 INFECTION ON ORAL CARE The rising awareness of oral hygiene COVID-19 has increased the demand for a product requires for oral care as the increasing studies for SARS-COV-2 indicated that proper oral hygiene has been reported to decrease the chances of infection which increases the demand for mouth wash, oral povidone solution, novel gargle solution. · However, due to restrictions and aims to reduce COVID-19 transmission, 30% of respondents had visited a dentist less frequently during the pandemic The second cause of increasing demand for oral care products is that approximately 90% of the product used in oral care are over the counter which can be added as the plus point in maintaining the demand for oral care products. The market players in oral care are also focused on the research to bring novel products to interstate commerce. For instance, · Microbac Laboratories, an independent and internationally accredited testing facility worked on behalf of Unilever Research Laboratories, has found that rinsing with mouthwash containing CPC Technology for 30 seconds is effective in reducing the viral load of SARS-CoV-2, the virus that causes Covid-19, by 99.9%. This type of research surge the demand for the oral product · Colgate-Palmolive President mentioned in an interview that they have seen elevated demand for oral care related to viruses, which also boosted the innovative growth related to a premium product This suggests that the increasing prevalence of COVID-19 poses precautionary measures due to which the global population started to take concern for their health hence enhance the demand for oral care. This thus signifies that COVID-19 is accelerating the demand of the oral care market. IMPACT ON SUPPLY The COVID 19 pandemic has affected and badly disrupted the global drug supply chain due to the continuous shut down of manufacturing facilities and restrictions imposed by the government over import and export activities. As per global sources, it was found that the beauty care business is still facing a crisis due to COVID-19. However, oral care market players are in a strong position. The two main leaders Colgate-Palmolive and Johnson and Johnson had seen a lift in sales in Q1 2020. Colgate-Palmoliva has net sales of USD 415 million for Q3 2020, up by 5.5% from the previous year. The surge of demand for oral care increased during COVID-19 however, the global restriction, and state-wise travel restriction has caused challenges for the market player. Moreover, there are many local players also in the oral care market that continued to fulfill the demand in case of any disruption. Oral care is categorized under essential need products which leads to the easy flow of these products. The main challenges during the pandemic is the supply of API’s and Ingredient or excipient used in toothpaste, as China holds the major share in API’s and other chemicals used in oral care and global restriction has somehow affected the supply chain for these products too. This, thus signifies that due to continuous lockdown and several restrictions by government authorities the companies and patients are facing disruption of the supply chain for oral care. However, oral care is categorized under essential care which lowers the effect of supply chain disruption during COVID-19. STRATEGIC DECISIONS OF MANUFACTURERS Collaboration, agreements, strategic initiatives, product launches by market players such as Colgate Palmolive, Hindustan Unilever among others in the oral care market will help them to expand their product portfolio and to provide appropriate products to the consumer. This in turn will lead to increased product sales and hence will put a positive impact on the overall company’s revenue. Oral Care product manufacturing companies are taking so many strategic decisions to cope up with the current scenario of COVID-19. The companies engaged in the manufacturing of toothpaste, mouth wash, gargle solutions among others are adopting several initiatives to accelerate the development of newer products and efficiently supply the product to different end-users. Companies have done collaboration and product launches between 2019 -2020 which supports the sustainable growth in the oral care market For instance, · In September 2020, Colgate Palmolive launched as first-ever vedshakti mouth protect spray, seeking their focus on oral hygiene during COVID-19. · Hindustan Unilever also planned to launch a mouth wash with 99 % in reducing SARS-COV-2 virus and has recently shared the preliminary data. · In April 2020, GlaxoSmithKline Consumer Healthcare Limited (India) merged with Hindustan Unilever Limited (HUL), with HUL responsible for the distribution of GSK’s Consumer Healthcare brands in India, including its leading oral healthcare brand, Sensodyne. · In April 2020, Perrigo Company plc (Ireland) completed the acquisition of the oral care assets of High Ridge Brands (US), which includes Dr. Fresh, LLC. · In December 2019, Colgate-Palmolive Company launched Colgate Optic White Renewal Tooth Paste. · In 2020, Colgate-Palmolive comes up with a recyclable toothpaste tube which will increase the interest of the population and surge the demand for the product leading to growth in revenue of the company Thus, companies operating in the oral care market are adopting several strategies, including collaboration, agreements, acquisition, and market expansion to enhance their business. These strategic decisions by the companies are expected to provide significant opportunities for the market players operating in the oral care market. CONCLUSION As the pandemic of COVID-19 has resulted in several restrictions throughout the borders but still, manufacturers of oral care can manage their stocks. Various manufacturers have allowed their manufacturers to work in a clean and safe environment to boost up the production of oral care categorized under essential need products at various manufacturing facilities across several regions of the world helping them to maintain a continuous supply chain. However, a decrease in doctor’s visit has impacted the market but the majority of products used in oral care are over the counter product which leads to continuous demand for oral care, and by raising the prices the companies are gaining extra profit which is helping them to combat the negative effect on overall revenue.
How COVID-19 Impacted on Nutraceutical Packaging in Healthcare Industry ?
COVID-19 Impact on Nutraceutical Packaging in Healthcare Industry The COVID-19 pandemic has impacted the food and beverages industry including the nutraceutical market by up surging in their consumption globally. Each and every segment of nutraceutical industry has been impacted either positively or negatively due to the COVID-19 pandemic. The Nutraceutical packaging market is subjected to have the positive impacts due to the sudden outbreak of COVID- 19. This is mainly due to the consumer awareness about the importance of consuming the nutraceuticals in order to boost their immunity to fight the pandemic period. The demand for the nutraceuticals has been increasing across the globe due to the changing lifestyle of the health conscious consumers. This increase in the demand for the nutraceuticals have positively affected on the nutraceutical packaging market. AFTERMATH OF COVID-19 AND GOVERNMENTS INITIATIVE TO BOOST THE GROWTH OF THE MARKET The aftermath of the COVID- 19 has a very positive impact on the market of the nutraceutical packaging across the globe. As the consumers are more incline to buy health and wellness products such as nutraceutical products which further increased the sales and revenue of the market players. The post pandemic period people are more concerned towards the product’s safety and shelf life which further drive the demand for advanced and innovative packaging materials for nutraceuticals. Also, with the growing awareness and growing social media nutritional trends influencing population all around the world will increase drive the demand for nutraceutical which will further boost the growth of global market. Many governments have taken initiatives for the nutraceutical packaging as they have been focusing on ways to improve the consumer’s health and wellness. The government initiatives to support industries in order to manufacture innovative packaging products will boost the growth of the market. For example, · European Union (EU)- funded project NanoPack aims to develop packaging solutions that increase product life after packaging by using novel anti-microbial surface application on the food packaging product surface. The Nanopack antibacterial film extends the shelf life of the product by two days. This two day increase in shelf life increase product stability by 40%. Therefore, such initiatives taken up by the governments which aim to help the manufacturers to manufacture safe products for the nutraceutical packaging will propel the growth of the market. STRATEGIC DECISIONS OF MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE To deal with the COVID-19 outbreak challenges many nutraceutical packaging market players are creating new strategies. It is predicted that these strategies are providing high chances to escalate up company revenue and its growth in the forecast period. Similarly, growing opportunities in innovative packaging solutions is attracting a larger consumer base for the nutraceutical packaged products. Increase in the demand for the nutraceuticals has made companies to launch the new products in spite of the COVID- 19 challenges and to gain a larger market share. Despite of the COVID – 19 pandemic outbreak, the manufacturers have been creating new opportunities by themselves by participating in exhibitions in order to spread the awareness about the nutraceuticals and their nutritional benefits which helps in boosting the immunity of the consumers. For instance, · In 2021, MJS packaging announced that they will exhibit for the first time since the start of COVID- 19 pandemic at the 2021 Cannabusiness international market place Michigan summit and expo in Michigan. Therefore, such product launches, exhibition of the products at the expos and vents in order to increase their consumer base are the strategic decisions which are taken up the market players to gain larger market share. PRICE IMPACT The COVID-19 had a terrible impact on the global economy. Many establishments have to remain shut while others scale down their operations or put on hold expansion plans as they survive the unprecedented crisis. The other impact of the COVID-19 pandemic outbreak is the delay or fluctuation of raw material supply for nutraceutical packaging manufacturing. This fluctuation has resulted in increase in price of raw material, which has impacted the prices of nutraceutical packaging products. IMPACT ON DEMAND There is a rapid increase in demand for the nutraceuticals increasing popularity for the nutraceutical packaging as well. Demand for the increased shelf life of food products across the globe is expected to increase the growth of the market in the COVID-19 period as well. There is an increasing consciousness about health and weight management is playing a crucial role in the demand for the global nutraceutical packaging market. On an average, the consumers have increased have increased their monthly spending on vitamins, minerals and supplements products by 10-15% since the COVID- 19 began. The increase in the awareness among the consumers about the consumption of the nutraceuticals is that they can build the immunity that is highly required in the COVID- 19 pandemic period has positively affected on the nutraceutical packaging as well. With the rise in the consumption of the nutraceutical in order to maintain the good health and fitness, the demand for the nutraceutical packaging also increased. Therefore, there has been a constant increase in the demand for the nutraceuticals which positively affected on the nutraceuticals packaging market as the packaging of the vitamins, minerals and other dietary supplements is the major factor that attracted the attention of the consumers. IMPACT ON SUPPLY CHAIN During the pandemic situation, the supply chain was majorly disrupted due to a lack of resources and transportation. Also, the governments across the world have implemented various restrictions and lockdowns to prevent the spread of the disease. In the same way, many governments have restricted the movement of goods across the countries and the entire supply chain was distorted. Owing to the disrupted supply chain, the transportation of raw materials has been interrupted and the production of nutraceutical packaging products was halted. Similarly, the manufacturers aren’t able to visit the customers such as nutraceutical companies to provide them with the packaging materials due to the implementation of lockdowns across the various parts of the world. Thus the demand for nutraceutical products has been tremendously increasing whereas the packaging materials production has been disrupted. As a result, the COVID- 19 pandemic has negatively impacted on the supply chain of the nutraceuticals packaging market. CONCLUSION COVID- 19 pandemic has taken a toll on the population and economy. A collaborative effort on governments, public health departments and hospital fraternity to fight corona virus has led to the economic slowdowns, lockdowns and extreme public safety measures. Due to the increasing health conscious ness among the consumers, the demand for the nutraceuticals has been increasing constantly in the COVID – 19 pandemic periods. This is mainly because of precautionary measures which are followed by the consumers for the COVID-19 which in involves the intake of nutraceuticals. However, the supply chain has disrupted during the outbreak scenario because the demand is more for these products. As unlocking of the lockdown being started in various regions of the world, it is expected that the supply chain became normalized for the market.
Liposuction Vs. Non-Surgical Fat Removal
Many cosmetic surgery patients are concerned about areas of unwanted, diet- and exercise-resistant fat. Localized fat can be difficult to get rid of permanently, whether it appears as a persistent stomach "pooch" after pregnancy, areas of fat around the thighs that won't budge, or bulges along the flanks and back. For many years, liposuction has been one of the most popular and frequently performed cosmetic procedures, and for good reason. This surgical procedure reduces fat and refines body contours in a safe, effective, and permanent manner. Nonsurgical or minimally invasive alternatives to liposuction have grown in popularity in recent years. These body contouring treatments usually do not require an incision or anaesthesia, and they have a shorter recovery time. Continue reading to learn about the differences between the two fat-loss methods and to determine which one is best for you. What exactly is liposuction? Liposuction is a surgical fat removal procedure that rose to prominence in the 1980s. A board-certified cosmetic surgeon carefully and precisely removes excess fat during the procedure using a small, hollow tube called a cannula. As the surgeon moves the cannula through the fat deposit, suction is applied, removing excess fat cells and sculpting a slimmer body contour. Liposuction is especially useful for removing fat from the legs, abdomen, back, arms, face, and neck. It produces more dramatic results than other noninvasive fat reduction procedures; however, it requires a recovery period of about four weeks and is typically more expensive than nonsurgical alternatives. CoolSculpting®, BodyTite®, and Other Nonsurgical Procedures: How Do They Work? Nonsurgical fat reduction treatments employ a variety of modalities to target and eliminate unwanted fat cells via a topical, rather than surgical, procedure. Nonsurgical body contouring treatments that are popular include: CoolSculpting. Allergan's CoolSculpting is a good choice for people who are close to their ideal weight but want to reduce small, localised trouble spots on the hips, abdomen, or thighs. A specialised cryolipolysis device is used in this treatment to cool unwanted fat cells to the point of death without affecting surrounding tissues. Fat cells that have died are flushed from the body in the days and weeks following the procedure. After three months, the final result is visible. TruSculpt. Cutera's truSculpt treatment is similar in that it uses controlled radiofrequency technology to eliminate fat cells on the hips, thighs, buttocks, and abdomen. The average treatment lasts about an hour, and most patients require one to two treatments to see noticeable results. BodyTite. BodyTite by inMode is a minimally invasive procedure that uses radiofrequency energy to tighten skin and reduce unwanted fat deposits. An internal probe delivers thermal energy to help melt fat and strengthen collagen bands beneath the skin's surface, while an external applicator delivers radiofrequency energy to the skin for additional tightening. BodyTite is considered minimally invasive because a small incision is required to insert the internal applicator probe by your surgeon; however, it is a less invasive procedure than liposuction. BodyTite is an excellent choice for people who have small to moderate amounts of excess fat and loose skin and want to avoid the extensive downtime associated with surgery. Most patients report seeing results within a few days, with final results appearing after 2 to 3 weeks. Patients can expect to see continued skin tightening in the months following their procedure because BodyTite stimulates collagen production in the skin. SmartLipo. SmartLipo by Cynosure, also known as “laser liposuction,” is a non-surgical procedure that uses triple wavelength laser technology to remove unwanted fat around the muscles and tighten loose, sagging skin. SmartLipo's laser gets to work dissolving body and/or facial fat, which your body then processes and excretes naturally. To remove any excess liquid that may accumulate during the procedure, a very small tube is inserted into the treatment area. SmartLipo is ideal for areas of the face that traditional liposuction cannot adequately address, such as the jowls, chin, jaw, and neck, due to the small tube used. SmartLipo is also excellent for contouring areas of the body that retain stubborn fat, such as the abs, back, flanks, thighs, buttocks, and upper arms. Because SmartLipo is less invasive than liposuction, there is less tissue damage at the treatment sites. The results of SmartLipo treatment are visible immediately, and there is little downtime required. SculpSure. SculpSure by Cynosure is a non-invasive laser body contouring treatment that removes unwanted fat beneath the chin (submental fat), love handles, the back, the stomach, and the inner and outer thighs. SculpSure, like CoolSculpting and truSculpt, is ideal for patients who are nearing their ideal weight but want to reduce stubborn, exercise- and diet-resistant fat pockets. Unlike CoolSculpting, which freezes fat cells, SculpSure uses heat to destroy fat cells (a process known as apoptosis). SculpSure has been shown in studies to be effective at permanently removing up to 24 percent of fat cells in a treated area. A series of 25-minute treatments is beneficial to the majority of patients. Nonsurgical Fat Reduction vs. Liposuction Both liposuction and nonsurgical body contouring have advantages and disadvantages. Invasiveness Liposuction is a more aggressive method of fat removal that causes trauma in the treatment area. For up to 10 days after the procedure, patients will experience soreness, bruising, and swelling. CoolSculpting, truSculpt, and SculpSure treatments are typically gentle and cause little discomfort during and after treatment. Results Although the final result of liposuction is not visible until 6 months after the swelling has subsided and the treated area has healed. CoolSculpting and other noninvasive fat reduction treatments take longer to produce results, which become more visible in the weeks and months following the procedure. While neither liposuction nor nonsurgical body contouring treatments can replace weight loss, liposuction does provide more dramatic and longer-lasting results, as well as some skin shrinkage. Downtime The healing process after liposuction necessitates that patients limit their daily activities for several days following the procedure and exercise with caution. CoolSculpting, truSculpt, and SculpSure do not require a lengthy recovery period, and patients can resume normal activities right away, though mild soreness and swelling are to be expected. Though the results of nonsurgical fat reduction will be less noticeable, you will be able to return to work and resume your life much sooner. Is Liposuction or Nonsurgical Body Contouring the Best Option for Me? For larger deposits of excess fat, liposuction may be an excellent option. It has the potential to significantly improve your figure in multiple areas at the same time. Some disadvantages include a higher cost and a higher risk of health complications when compared to noninvasive techniques. If you are already at your ideal weight, have good skin elasticity, and want to target smaller, stubborn trouble spots, nonsurgical fat reduction may be a better option. The results, however, will not be as dramatic, and multiple treatments may be required. Making an Appointment for Liposuction or Nonsurgical Fat Removal The best way to decide between liposuction, CoolSculpting, truSculpt, BodyTite, and other non-invasive fat reduction procedures is to consult with a board certified cosmetic surgeon. During a personalised cosmetic surgery consultation, they can walk you through your options and help you decide which is the best fit for you.
How COVID-19 Impacted on Veterinary Vaccines in Healthcare Industry ?
COVID-19 Impact on Veterinary Vaccines in Healthcare Industry The animal health sector has witnessed significant developments over the past couple of years due to technological developments and efforts in Research and developments in veterinary sciences. One of the essential developments is antigen location using multiple bioinformatics methods and has been effectively used to immunize against various veterinary illnesses. Vaccines are a helpful to use way to protect animals against a variety of diseases. Vaccinology has produced several potent vaccinations that have significantly decreased the burden of certain severe illnesses in companion animals and cattle. Most approved veterinary vaccinations are available in live attenuated, killed/inactivated microorganisms, cell membrane compounds, or toxoids. The recent COVID-19 has an adverse the veterinary vaccines market as many animal drugs and vaccines were approved for human use. Animals infected with the virus have been reported all around the world. The majority of these animals, including a small number of domestic cats and dogs, got infected after coming into contact with people who had COVID-19. SARS-CoV-2 may infect companion animals like cats and dogs, large cats in zoos or sanctuaries, gorillas in zoos, mink on farms, and a few other mammals, but all of the species that can be infected in not been researched. Hence, the veterinary vaccines market is expected to play a vital role amidst the COVID-19 pandemic. IMPACT ON DEMAND The novel COVID-19 outbreak has led to a considerable rise in the demand for the veterinary vaccine. Veterinary offices worldwide made significant adjustments to guarantee that animals and livestock receive necessary veterinary care and that new safety procedures are in place to safeguard animals and veterinarians. As COVID-19 spread rapidly across the world and healthcare infrastructure became overwhelmed with COVID-19 cases. Coronaviruses can infect various domestic animals, including dogs, cats, cattle, pigs, and poultry. Routine vaccination can prevent many of these diseases. Vaccines against the canine coronavirus were in demand to protect puppies, although the illness is mild and self-limiting. In response to the surge in demand for veterinary vaccines, many veterinary producing companies were directed for the human COVID 19 vaccine, which impacted the production of veterinary vaccines. FOR INSTANCE- · In May 2021, Amid a shortage of COVID-19 vaccines as the country faces the second wave of infections, Bengaluru-based Institute of Animal Health and Veterinary Biologicals (IAH&VB) has offered to provide its state-of-the-art vaccine production facility to produce the vaccines IMPACT ON PRICE The veterinary services and vaccines prices were impacted due to COVID-19 up to some extent. Factors responsible for it were access to farming inputs, such as animal feed, livestock movements for pasture and water, animal equipment vaccinations, and other critical production inputs. Appeals to stay at home and social distance have had an impact on the pricing of veterinary vaccines. There been a whirlwind past months due to the emergence of COVID-19. The sale of some companies experienced a downfall while others managed to stay afloat. FOR INSTANCE, Common illness transmitted between species includes swine flu (H1N1), anthrax, and West Nile virus, to name a few. With more than 94.7 million cattle in the U.S. as of 2019 and more than 74.6 million pigs, the risk of zoonotic diseases transmitting to humans is a risk. It had an increase in prices for the veterinary vaccines IMPACT ON SUPPLY CHAIN The government throughout the globe imposed total lockdown, which led to supply chain disruptions. Consequently, the supply chain came to a standstill due to the closure of borders. Even though the demand for these devices was high, the availability was affected due to disruptions in the supply chain, trade, and travel restrictions. Supply of raw material was also affected, due to which the production was restricted. Veterinary services, such as routine vaccinations and testing and diagnostic instruments, were short supply for many farmers. As a result, animal illness control has emerged a new task that coincides with animal welfare concerns. However, the impact of COVID-19 on animal healthcare operations is not limited to the farm level; there are also national and international limitations. Due to funding constraints, several national and international animal health care programs/projects have been postponed or discontinued, limiting the success of disease elimination due to COVID 19. Several companies working on veterinary vaccines have indicated that the reductions in fluidity and foreign exchange were other significant factors affecting the sustainability of the livestock supply chain, specifically in developing countries during the pandemic. FOR INSTANCE: · The E.U. Executive Steering Group on Shortages of Medicines Caused by Major Events has provided strategic leadership for urgent and coordinated action to prevent and mitigate supply disruption during the pandemic The European Commission chairs the steering group. It consists of representatives of EMA, the European Commission, Heads of Medicines Agencies (HMA) and the Coordination groups for Mutual Recognition and Decentralised Procedures for human and veterinary medicines (CMDh and CMDv), as well as risk communication specialists PERSPECTIVE AND INITIATIVES: As the reality of COVID-19 dawned upon the world, the manufacturers and production units of companies involved in veterinary vaccines manufacturing industries and governments had various perspective and initiatives taken regarding the market. FOR INSTANCE: · In July 2021, Minister of Agriculture and Land Reclamation El Sayed El Quseir discussed investment in the production of veterinary vaccines and serums with Dr. Chris Nelson, Management Advisor of the Egyptian-American Middle East for Veterinary Vaccines (MEVAC) pharmaceutical company and President and CEO of the U.S. Kemin Industries · In July 2021, Zoetis donated more than 11,000 doses of its experimental COVID-19 vaccine to help protect the health and well-being of more than 100 mammalian species living in nearly 70 zoos, as well as more than a dozen conservatories, sanctuaries, academic institutions, and government organizations located in 27 states in new jersey CONCLUSION COVID-19 has impacted each sector with no exception. The veterinary vaccines market has been affected the same. With rising awareness around of vaccination against cattle diseases and improved health facilities for animal husbandry, there is a rise in demand for veterinary vaccines up to some extent. However, in the crisis call veterinary vaccine manufacturers, key players, government bodies, and healthcare organizations are working closely with healthcare professionals, customers, and patients for the betterment of animal health. Moreover, animal drugs and vaccines were approved for human use. Animals infected with the virus have been reported all around the world. Also, veterinary vaccine manufacturing facilities were used for production of human COVID vaccines around the worked. This is expected to impact the market for veterinary vaccines up to some extent.
How COVID-19 Impacted on Niemann-Pick Disease in Healthcare Industry ?
COVID-19 Impact on Niemann-Pick Disease in Healthcare Industry OVERVIEW A novel coronavirus, SARS-CoV-2, appeared in December 2019 in Wuhan, China, spreading much faster than its predecessors and has already infected millions of patients worldwide as of April 19, 2020. As the scope of the current COVID-19 outbreak has reached the proportion of pandemics, significant international efforts in public health are underway to control the epidemic. The covid-19 pandemic majorly impacted the rare diseases patients because, during the pandemic, the need to provide high-level care for a large number of patients with COVID-19 has affected resourcing and limited the routine maintenance of all other conditions. The impact of health emergencies particularly faced by the rare disease communities, organizations, clinics, and other healthcare providers. The health economic challenges faced by patients and their families, institutions, research organizations, and healthcare providers during the pandemic outbreak have demonstrated the importance of ensuring continuity of care in the management of rare diseases, including adequate diagnostics and monitoring protocols, and highlighted the need for a structured emergency strategy. Niemann-Pick disease is a rare, inherited disease that affects majorly body's ability to metabolize fats such as cholesterol and lipids within the cells. Over time, these cells got malfunctioned and died. The disease can affects the brain, spleen, nerves and, if get severe, may affect lungs, bone marrow, and other organs. The disease can occur at any age but majorly affects children. There is no known cure for the disease, and sometimes it may be fatal for children, the only treatment is focused on helping people live with their symptoms. IMPACT ON PRICE Various market players are facing a large number of challenges due to the coming of the novel coronavirus and different strains; one such issue is the uncertainty surrounding the impact of covid-19 on off label drugs demands. Due to the increased coronavirus cases and continuous lockdown, the costs of the drugs and their APIs increase automatically. On the one side, it will increase the revenue of the companies, but a patient may resist buying the products, which ultimately increases the stress level on the patients. Moreover, Due to the pandemic, there is the delay associated with various types of limitations faced by the manufacturers to fulfill the end product order, which has resulted in the less availability of medical devices in the market and due to which the cost of available devices has increased with the several factors. Also, due to the Coronavirus disease (COVID-19) pandemic outbreak, manufacturers are forced to find new contract manufacturers and suppliers for more manufacturing activities to different or unique facilities location that are less impacted by the outbreak. The impact of Covid-19 has created huge price impact on the government as well as on patient families that they have to buy the drugs on higher rate as compared to the average rate. IMPACT ON DEMAND The Coronavirus zone is the result of various markets around the world. This is the cause of the widespread closures and isolation that are affecting world economic activity. As the cases increases in the month of April 2020, the sudden surge in demand has seen, and drugs and medical devices went out of stock. Moreover, the decrease in the revenue of the key market players depicted in their quarterly results, such as Medtronic, among others, gave the evidence of decline in the demand for medical devices due to the emergence of the COVID-19 pandemic. For instance, · Medtronic reported a decline of 1% in its brain therapies net sales of the financial results of 2020 as compared to 2019. The reduction was primarily motivated by the detrimental effects of the COVID-19 pandemic and the subsequent deferral to companies of medical procedures. · Impact on rare disease organization also faced significant fundraising income loss, this consequential income loss may leads to loss of various people jobs associated with the organizations. The cutting or income loss leads to the reducing staff, canceling offices leases, and delay or cutting office programs. The impact of covid-19 majorly impacted the organizations if the revenues loss projections do not change, this will leads to temporarily or permanently shut down of small and middle foundations and organizations. IMPACT ON SUPPLY As the epidemic intensifies, supply chains can be at significant risk due to over-located locations that can potentially be disrupted. The supply chain of drugs, devices, and services has been disrupted. The spread of COVID-19 makes it difficult for governments to use these drugs; the availability of these systems faces constant challenges due to their components of use and limited initial needs. Moreover, as there is no cure for the disease, only physical activities/therapies may suppress the symptoms also affected by pandemics. According to the NORD (National Organization for Rare Disorders), in the U.S. stated that 74% of the population have had canceled medical appointments due to Covid-19 pandemic, 69% of population concerned about their medication and medical supplies. For instance, • In June, ResMed stated that, due to the Covid-19 pandemic company sleep apnea business segment adversely affected including sleep clinics, physician practices, HME suppliers. As new patients are prescribed sleep apnea devices such as PAP, CPAP devices for the treatment through hospitals that are directing their resources to critical care, including COVID-19 treatment. The covid 19 impacts may continue to decrease demand for the sleep apnea devices sale STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS As such, market participants are involved in the production of drugs, expanding their business through a variety of programs, including collaboration, contracts, and pipeline development, collaboration, and market expansion. It is expected that the strategic decisions of these companies will provide significant opportunities for market participants operating in the Niemann-Pick Disease market. For instance, · In July 2020, Abbott announced that it had received FDA approval for the use of the Patient Controller App on compatible personal Apple smartphone devices. The approval will allow the patient living with neurological conditions to manage their therapy directly from personal smartphone. · In May 2020, Philips, a global leader in health technology, joined forces with the American Telemedicine Association (ATA) to help further the adoption of telehealth across the industry, demonstrating its commitment to connecting care across acute, post-acute, and home care settings. The continued collaboration spotlights telehealth's growing adoption and momentum amidst COVID-19 and the need to convey the exponential shift to telehealth capabilities. · In U.S., NIH supports the research survey of “CURE EPILEPSY ORGANIZATION” to examine the impact of Covid-19 on Rare Disease Community. The survey includes more than 200 rare diseases including the brain, immune system disorders, heart, lungs, brain development diseases, and more. CONCLUSION As this pandemic situation has resulted in many restrictions in different places around the world, still the market players of dealing in rare diseases therapy and services were able to manage their service stock. Different companies dealing in metabolic diseases therapy services were finding out their own way to deal with this pandemic situation. The government and companies around the globe are working together and have issued advice for those undergoing therapies centers during these unprecedented times during COVID 19 lockdown around the world. The supply chain was destroyed, but several steps were taken by the government and companies, which will help them, get their needed output for therapy service. By increasing the material price, the companies can maintain their overall revenue. Thus, different foundations, organizations,, and services center markets are finding ways to deal with this pandemic situation. Figure 1: Relationship between Coronavirus and Lysosome storage diseases : Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway
Pure Form Keto - Reduce Your Unwanted Belly Fat In Just Few Weeks !
A keto diet plan is the better diet regime which comprises generally small carbs and fats. In popular cases, we utilized to have a good amount of carbs. The majority of the nutrient count in the day by day every day life is constructed or carbohydrates. It is because your body typically works by using carbohydrates in the interests of vigor. But with keto eating plan, the body will require more saturated fats as opposed to carbs. Your body energy is transformed all over the body and you will slimmer than ever before, because of this reason. Those who are not able to follow the keto eating habits can have a preference for for those substitute beneficial supplement known as Pure Form Keto  which offers beneficial outcomes for the conclusion people. ALSO READ : Keto Surge {Ketogenic} : Fat Burning As Fuel And Boosting Energy ! Just What Is Pure Form Keto? Pure Form Keto is regarded as 100% all natural weightloss nutritional supplement which supports in losing yourself excess weight and make it easier to take a slimming body. This is considered the remarkable losing weight nutritional supplement produced for each men and women. It aids in getting rid of the located human body fatty acids And is great for finding muscle you have dreamed of. Right up until now, plenty of people have chosen this product with regard to weight reduction so because of this employ this approach on consistent basis. Not one of the prospects carries a complaint regarding the adverse influence of the supplement. How Might Pure Form Keto Work? Pure Form Keto is regarded as the ideal fat burning supplement as it works by using saved body system saturated fats to build the mandatory power for your body. Considering the fact that fat is known as the ideal way to obtain electricity, it permit your whole body for making busy and stay full of energy for too long period of time than the regular time. On top of that, the consumption of this health supplement paves opportunity for a decrease in insulin levels of the body so because of this amplifies excess fat burning up approach easily. In addition, it aids in having the ketosis declare during the limited time time period. Becoming a protected purely natural supplementation, the surgeon suggests this particular product as the best choice for earning needed ketosis. Everyday consumption of this dietary supplement is tremendously valuable for your body to manage the blood sugar levels amount existing within your body. Therefore, it is really valuable for anyone who are suffering out of the problem of type two diabetes. ALSO READ: Fastgenix Keto : Get Your Own Stunning Result With Ketogenic diet ! Energetic Elements Found In Pure Form Keto Pure Form Keto is produced working with herbal and natural substances which has the inclination to raise ketogenesis with your entire body. This supplement enables you to restrict carbs & to produce sugars nutrition current inside you which energizes the technique of thermogenesis in the human body. The foremost substance utilized in this supplement is provided beneath: • The significant factor employed in the fat burner nutritional supplement is BHB (Beta-Hydroxybutyrate). This is the primarily ketone found within the body at the time of ketosis approach. • It permit your system to shed apart excess fat to develop required power rather then using cabohydrate supply. It also raises the rate of metabolism hormone of the body. • Also, it is quite useful in stopping the fat deposition located within your body hence helping you to slim down substantially. • BHB have a tendency to cross various boundaries present inside your body. One such buffer is known as a blood stream-neurological hurdle that is regarded as a really governed program. Though the ketone is highly efficient at traversing on the barrier And does the work of weight reduction correctly. As a result, it aids in enhancing mental faculties function and forces you to completely focus far more. ALSO READ: Ideal Beauty 365 – Ketogenic Fat Burner Using Ketone Diet Boost Energy Focus ! Great things about Pure Form Keto • Melts absent all round unwanted fat • Builds lean and strong muscle tissue • Superior neurological operate • 100% natural and safe for consumption • Helps with quick weight loss • Good at attaining a condition of ketosis Drawbacks of Pure Form Keto • You will find only minimal solutions seen on the state internet site • In case you are struggling with every other medical condition then quit taking this product • This product is absolutely not ingested via the people under 18 years old • It really is available only in internet vendors rather than in conventional retailers ALSO READ: Royal Keto Max : Ketogenic Booster Diet Pills For Women And Men ! How To Take Pure Form Keto? To receive best results out of the Pure Form Keto product, you need to have 2 tablets a day having a glass of tepid water. Moreover, limitation your regular diet to keto welcoming supplement. Still acquire this losing weight dietary supplement for a few-month timeframe. Make your self hydrated by sipping about 4 to 5 liters water every day. You can also think about the specialist suggestion to look at modify in the body pounds inside of some days. Pure Form Keto Side Effects This weightloss product has become tested and approved scientifically from the medical doctors to become the trusted product or service. It has been usually utilized by lots of people and it has helped all uses up and there is absolutely no document of negative effects right up until now. Those who are directly below 18 years old should never occupy this product. It is far from intended for treating any sickness quite it is actually aimed at supplying weight reduction so that you will have to never try this supplement when you are struggling with health conditions. It is recommended asking your doctor before taking up this supplement if you suffer from any medical history. ALSO READ : Pharma Pure Keto - Weight Loss Diet Pure Keto Burn Fast Exogenous Ketones Why Should I Prefer Pure Form Keto? If you are not consuming sufficient ketogenic foods or if you are not following proper ketogenic diet then you can opt for the suitable supplement as the best substitute. You will find different varieties of supplement accessible that will support yourself to get ketosis so you can use several benefits which your whole body would like for. Pure Form Keto is known as the effective dietary supplement which will make your system obtain ketosis in a very more suitable manner. This product is established in the interests of weight reduction & it facilitates the people who have failed to cut down pounds of excess weight via other ways of weight-loss. Commonly, individuals usually follow an exercise routine program but it does not perform if you are far too occupied or lazy to see the gym everyday and conduct training at your house. Pure Form Keto is the best choice to lose your weight substantially. Click Here To View Pricing and Availability Where To Obtain Pure Form Keto Supplement? Pure Form Keto product can be obtained from the online sites. By placing your order on this supplement, it will be delivered at your doorsteps in 5 to 6 working days. You can place your Buy in the near future from the standard website to get huge discount rates and offers. Moreover, you can avail free trial of this product so that you can order if you are satisfied with the product. If you are not satisfied with the product then you can avail 100% money back guarantee. As a result, the product ensures for sufficient weight loss you want for.
Significant COVID-19 Impact on Non-Small Cell Lung Cancer Diagnostics in Healthcare Industry
COVID-19 Impact on Non-Small Cell Lung Cancer Diagnostics in Healthcare Industry The novel coronavirus has profoundly impacted all fields, including healthcare, medical device services, automotive, pharmaceutical and many others. This pandemic has led to shutdowns of mass production and disruptions in the supply chain that have impacted the economies of virtually every nation in the world. The pandemic also affected the non-small cell lung cancer diagnostic industry. The patient's fear of contracting the virus compels patients to stay home instead of undergoing diagnosis and treatment. During the COVID-19 pandemic, countries worldwide witnessed a large number of patients suffering from COVID-19 and post COVID-19 complications such as cardiovascular disease, diabetes and kidney problems. As the COVID-19 cases were rising, the healthcare system had shifted its focus in curbing the disease, thereby delaying diagnosis and treatment of other chronic conditions as cancer. Thus, a negative impact is expected on the non-small cell lung cancer diagnostics market due to the pandemic scenario As a result, the hospitals and clinics were filled up with COVID-19 patients and less preference was given to non-small cell lung cancer patients. Moreover, limited access to clinics, social distancing, the lockdown of the population, which results in a slow-down in patient flow and referrals, has also impacted the market growth. However, with the cases decreasing in number and increase in vaccination against COVID-19 across the globe, the market for non-small cell lung cancer diagnostics market may get a boost due to some relaxation in COVID-19 cases, which will result in increased demand for non-small cell lung cancer diagnosis with patients coming forward to clinics and hospitals for treatment. IMPACT ON DEMAND Various screening, diagnostic and surgical procedures were restricted and at hospitals and cancer treatment centers, which resulted in disruptions in the non-small cell lung cancer diagnostics market. However, even during the pandemic, the lung cancer cases were subsequent, which is expected to increase the demand for non-small cell lung cancer diagnostics market. For instance, · According to World Health Organization (WHO), in 2020, lung cancer accounted for 2,206 771 deaths among both sexes. The lung cancer statistics include both small cell lung cancer and non-small cell lung cancer. About 13% of all lung cancers are small cell lung cancer and 84% are non-small cell lung cancer. This proves an increase in the number of non-small cell lung cancer patients even during the COVID-19 pandemic. Moreover, according to the American Cancer Society, Inc., lung cancer patients are likely to get infected with coronavirus because of the changes in their immune system that control their body's defense systems. For instance, · According to a study published in PubMed, patients with lung cancer are at an increased risk of becoming infected with the virus and experience higher morbidity and mortality than the general population Thus, having cancer such as non-small cell lung cancer may also increase the risk of severe illness from COVID-19 as the cancer therapy treatment reduce the immune system of the body. . This has increased the demand for non-small cell lung cancer diagnostic tools, especially in cancer-dedicated hospitals and surgical centres, where all the patients of non-small cell lung cancer-related problems are treated. Thus, with the increased lung cancer cases, the demand for non-small cell lung cancer diagnostic will increase in the coming years. IMPACT ON SUPPLY CHAIN The supply chain was widely affected by the COVID-19 pandemic as acute restrictions and lockdowns produced many urgent situations in the early days of the pandemic, which needed immediate attention. The supply chain disruption has transformed many organizations' business environments, including the supply chain of non-small cell lung cancer diagnostics market. The supply chain disruption impacted the Asia-Pacific region initially, especially the demand from China due to challenges from restricted movement and quarantine period. For instance, · According to the FDA, 63 manufacturers representing 72 facilities in China that produce essential medical devices face obstacles in manufacturing medical devices and their supply, owing to citing workforce challenges and the necessary quarantine of workers. Moreover, closing borders of various countries is anticipated to diminish the supply chain business environment, as it may hamper export of the medical supplies To minimize supply chain crises, the FDA has been firmly monitoring the supply chain with the assumption that the COVID-19 outbreak may adversely impact the supply chain of medical products, including shortages of critical medical products in the U.S. or potential disruptions in supply chains. Many organizations and countries are looking forward to improving and diversified supply chain models in all aspects to manage such a crucial situation. A diversified supply chain model anticipated minimizing the export of medical products as well as increase end-to-end visibility. For instance, · The Brazilian government published a resolution eliminating import taxes on 141 medical products and hospital equipment · The European Commission made a decision for helping Member States affected by the pandemic to suspend customs duties and VAT on medical devices temporarily · Federal indirect tax body the Goods and Services Tax (GST) Council of India has decided to cut taxes on medical supplies IMPACT ON PRICE The coronavirus disease (COVID-19) pandemic does not significantly impact the global non-small cell lung cancer diagnostics market. But it is estimated that if COVID-19 continues to spread for a prolonged period, then the demand for non-small cell lung cancer diagnostic equipment and devices will highly upsurge for top importer countries. For therapies and the diagnostic United States solicit the huge number of medical devices, followed by China and Japan. For instance, · According to the General Administration of Customs (GAC), China's exports of medical machinery and devices increased 40.5 percent in 2020 compared to the previous year, reaching USD 18.138 billion · According to the World Trade Organisation, the U.S. imports and exports of medical goods increased by 16 %, reaching USD 1,139.00 billion in value Henceforth for diagnosis, dependency of these countries highly increases on other exporters and many countries solely depend on China and the U.S. for the non-small cell lung cancer diagnostic equipment. Consequently, this may lead to a rise in the overall non-small cell lung cancer diagnostic cost. This increase in the price of the non-small cell lung cancer diagnostic may hamper the market growth if it continues to be the same. Additionally, if the lockdown continues to stretch for a long period, then import of non-small cell lung cancer diagnostics market is estimated to get more restricted, which may further lead to a rise in the price of the these devices CONCLUSION It is estimated that the COVID-19 pandemic outbreak has significantly impacted the growth of non-small cell lung cancer diagnostics market as the rising cases of COVID-19 worldwide the healthcare system had shifted its focus in curbing the disease, thereby resulting in the delay of diagnosis and treatment of non-small cell lung cancer. Thus, a negative impact is expected on the non-small cell lung cancer diagnostics market due to the pandemic scenario. However, with the increase in lung cancer patients worldwide, the demand for non-small cell lung cancer diagnostics will increase in the coming years. Moreover, poor lifestyle, smoking, alcohol consumption, lack of physical activity and other factors will contribute to the incidence of chronic disease such as lung cancer, including non-small cell lung, which is anticipated to increase the global non-small cell lung cancer diagnostics market in the coming years.
COVID-19 Impact on Healthcare Robots in the Healthcare Industry
COVID-19 Impact on Healthcare Robots in the Healthcare Industry As the deaths from the COVID-19 pandemic start to increase, the World Health Organization (WHO) has urged citizens to maintain specific social distances. In an attempt to avoid the spread of COVID-19 at the population level, medical robots or healthcare robots are gradually involved in the roles of sanitizing patients' quarters, distributing medications, and supplying meals to ill people. Supplying supplies to households and delivering effective services to injured patients remained a major obstacle, and this is where healthcare robotics is creating a space for them. The new pandemic is growing in demand for healthcare robots as they play a crucial role in the process of drug distribution, patient evaluation, and medical workers' infection control. COVID-19 Market Effect The 2002-2004 SARS pandemic has indelibly altered the business climate for healthcare robots. Nearly 8,000 people were affected and 700 were killed. In addition, MERS affected 200 and killed about 40 of them. They were all limited to different territories. COVID-19, on the other hand, as a pandemic, has had a larger influence on the global economy. The SARS and MERS outbreaks contributed to a new era of creativity with the advent of disinfection robots that produce UVD light to combat against infectious viruses and bacteria on hospital surfaces. If COVID-19 continued to grow globally, UVD robots makers would expand significantly, and if the pandemic was bought under control, healthcare robots would be developed exponentially to decrease the risk of infective infection in hospitals. The healthcare robots market was expected to hit with a significant growth rate in 2020-2021. Owing to production reductions and supply distresses, the healthcare robotics demand was minimally affected in 2020. That would contribute to a decline of BPS 180. But the sector is now starting to see blue sky as the main development region such as China is beating the recession and moving up. Succeeding in the Wake of the Emergency Healthcare robots can play a critical role in the current pandemic by reducing human involvement and shielding health staff from infection. This will involve measuring patients' temperatures, disinfecting equipment, measuring specimen swabs and delivering much-needed psychological assistance to patients in isolation. Researchers are now beginning to illustrate the cyclical aspect of technology right after the recession. The COVID-19 contraction would accelerate labor-replacement automation as business sales see a fall. This might have arrived during the 'cultural shock' as automation eliminates low-skilled jobs. The prospects for healthcare robotics exist in the introduction of smart navigation and the detection of high-risk and highly contaminated environments. Wireless networking systems in healthcare can include drones, telemedicine, and decontamination with AIdriven capabilities. Healthcare robotics should see early acceptance in regions first hit by the infection, offering them an advantage. The companies in China are now doubling their revenue production from the previous years. By the time the pandemic is done, robotics should be distributed through a variety of facilities and programs. The manufacturing will experience reshoring, with decreased reliance on countries such as China, and one way to do so would be by robots that would support the robotics industry. Disinfection Robots UVD Robots, a Danish corporation located in the University of Odense and Blue Ocean Robotics, is a leading manufacturer of disinfectant robots for China in the fight against the spread of the virus. The firm signed a deal with Sunay Healthcare Supplier in February and has since delivered dozens of its self-driving robots to clean hospitals and other places with ultraviolet light. The firm claimed that this reduces the transmission of coronaviruses without exposing medical workers to the possibility of infection. Since then, the firm has marketed robots to locations in more than 50 organizations, extending its services outside China to places in Europe and the United States that are facing epidemic issues. UVD Robots frequently accepts inquiries from outside the hospital and medical institutions, including prison, offices, production floors, department shops, malls, airports, hotels, and restaurants. Dimer, located in Los Angeles, provides its GermFalcon UV-C robotics equipped to clean aircraft and its UVHammer robotic systems for hospitals and complex settings. In mid-January, the organization provided its services to the first three major U.S. airports where Chinese arrivals took place. Xenex confirmed that its LightStriken germ zapping robots became the first hotel in the U.S. to sanitize or clean guest rooms and communal areas at the Westin Houston Medical Center. The technique developed by two epidemiologists in Houston will easily kill pathogens, bacteria and fungi by utilizing strong pulsed xenon ultraviolet radiation. The MTR Company, which runs the Hong Kong subway, has confirmed that it is partnering with Avalon Biomedical (Management) Limited to build the VHP Robot, which stands for the vaporized hydrogen peroxide system. The robot conducts deep cleaning and decontamination in train compartments and stations to secure passengers and workers. More than 30 disinfection robots developed and manufactured by TMiRob, a company in Shanghai, have joined major hospitals in Wuhan, the hub of the novel coronavirus outbreak, to counter the epidemic. The white robot deployed by the firm has a hydrogen peroxide sprayer on its "front" and nine ultraviolet lamps in its "belly" and can conduct various types of disinfection in areas where humans and machines coexist, navigation hardware allows the system to clear hazards independently. Beijing-based robotics firm CloudMinds sent 14 robots to Wuhan, China, to assist with medical treatment in the wake of the coronavirus pandemic. Robots, some of which are more humanoid than others, can scrub and disinfect, distribute medications to patients and check the temperature of patients. CloudMinds contributed robotics to a number of medical institutions in China, including the Wuhan Wuchang Smart Field Clinic, which was converted from the Hong Shan Sports Centre. An Israeli-made AI robotic assistant is being used in hundreds of clinics, community centres, nursing homes and industrial buildings in Asia to eliminate human-to-human interaction as millions of people take precautions for a current coronavirus epidemic worldwide. Israeli company Robotemi, a creator of the Temi robot assistant, claims the device has already been sold to hundreds of locations throughout South East Asia, including China, Japan, South Korea, and Hong Kong. Healthcare Assistance Twelve sets of robots were provided into an intelligent hospital in Wuhan, China by CloudMinds, a supplier to A3, to support the health workers overstressed and threatened. The robots carried out many important tasks including flagging patients who had a temperature, pulse rate, and blood oxygen rates and medicine at the entrance to the field hospital. Such robots have also cleaned and disinfected the hospital areas and performed fitness exercises for patients with the disease. In addition, Chinese researchers modeled the arm of a robot on wheels that can ultrasound, swab in the mouth, and hear the noises produced by a patient's organ normally with a stethoscope. The robot will conduct these activities with cameras in the same space without having to provide medical staff. Professor Zheng Gangtie from the University of Tsinghua developed the device. Unmanned Vehicles Unmanned vehicles and other autonomous robots are deployed in China's virus-affected regions. For instance, Beijing JD Logistics has sent two unmanned L4 class vehicles to Wuhan, and engineers have driven the vehicles remotely through the cloud. Another firm, Idriverplus, has donated an unmanned transportation vehicle to Shanghai and Beijing hospitals. Amazon revealed that it will recruit 100,000 workers to deliver products in vacant warehouses to purchase during the epidemic. The area of e-commerce is now growing with the usage of robots to fill orders and this increase is projected to accelerate as more customers shop digitally, while they remain home more. Teleworking Robots The use of video and audio conference software as companies including Zoom, Microsoft (Skype) and others providing interactive meetings services has expanded with millions of citizens still operating at home because of the state and nation lockdowns. However, businesses of telepresence robotics do have greater interest of their apps, but not for the same purposes. As a consequence of the latest epidemic of coronaviruses, Ava Robotics is building handheld telepresence robots for many years. According to the CEO and cofounder of the firm, the increasing number of hospitals and nursing homes are interested in the robots, which enable the family to talk to patient and older residents on video as a consequence of the policy of 'no visits' and lock-outs in these places. Owing to the need to be simple to use on one end of the line-an aged or ill user in this situation, Ava robots are distinct from the machine enabled video-conferencing device used on a phone or a computer. The company works to make it simple for robotics setup people to click on a connection and talk to the telepresence robot instantaneously. In parallel to the robot's operation, hospitals have utilized Ava robotics, primarily for triaging through the coronavirus. For starters, the robot is configured to remotely test patients with Ava robotics after the initial appointment in one of Boston's largest hospitals. It's also the machines that patients use to reach and depart a position often-rather than people, the system will do it to save the medical equipment because a person has to wear a face mask, shoes and gloves every time instead of human operation. Initially, Czartoski, a practicing neurologist, was utilizing telemedicine in the care of stroke survivors, one of the strongest early lead for telemedicine. According to him, "If I encounter anyone with stroke signs, I will test them with a camera relatively easily to inform them if there is left side fatigue to speech problems, then I will look at the CT scan and the results then make a recommendation for the ER specialist." Virtual visits are growing in the providence. The non-profit health care network conducted nearly 100,000 virtual appointments in 2019. In 2012, the providence carried out a few hundred telemedical visits a year and was rising at a fast pace — from 12,000 in 2016 to 41,000 in 2018 to more than 100,000 last year. That figure does not explicitly reflect the usage of telemedicine in the ICU. Pharmaceutical Assistance Pharmaceutical firms tend to work on viral vaccinations or therapies and automation businesses have developed electronic tools to further simplify manual and replicate processes over the years. The robotics firms also provide options for businesses seeking to combat the COVID-19 virus. The two new modular, ready-for-assay workstations, focused on the Microlab STARlet liquid handling system, were announced recently by Hamilton Group. The latest technologies will help render the SARS-CoV-2 coronavirus that triggers the current COVID-19 quick and highly effective diagnostics, and research-based testing, said the firm. The MagEx STARlet allows the extraction of biological samples from high-performance RNA-based magnetic beads, the PCR Prep STARlet workstation is pre-configured and eligible for sample deployment utilizing recent protocols from the centers. Furthermore, the robotics designed by businesses is actually being employed in the war against coronavirus. ABB robots can be seen in this ABC news story to help a medical laboratory with the development of COVID-19 research kits. Healthcare Robots Market Synopsis The new pandemic will be targeted by health-care device vendors. They will be aligned on developing, unregulated markets with tech firms, stressing the value for national emergencies of healthcare robots. Many industries such as Enterprise Resource Planning (ERP) for higher profit margins are often impacted, in combination with robotics. Medical personnel's are predicted to become a potential phenomenon in patient events, raising the incidence of disease infections. According to the International Federation of Robotics (IFR), the shipments of medical robots already have increased by 50% in 2018. The outcome of coronavirus, however, illustrates some of the essential situations in which robotic systems may be disinfected, tracked, controlled and supplied. The World Robotics study shows that Europe is the most robot-densely inhabited region in the world with an estimated size of 114 units per 10,000 employees. In Edinberg in the United Kingdom, robotic engineers are operating on what they believe is the first safety device to speak to more than one human concurrently. The initiative was planned to support disabled citizens. Scientists say that the discovery will aim to counter potential waves of diseases such as the pandemic. Throughout the United States, the COVID-19 patients are housed at the Providence Community Medical Center throughout Washington in remote locations with two rooms. A robot, which has a microphone, a stethoscope and a camera, is being used by physicians. It helps doctors to interact individually with patients without touching. Disinfection UVD robots in China has been widely searched after as a consequence of the outbreak. The robot built by Denmark's blue ocean robot is ordered by a significant number of hospitals in the world. In the epidemic epicenter of the Wuhan outbreak, these robots played an important part. As time passes, robotics plays a significant role in fighting diseases such as COVID-19, similar to other technologies. Robot technologies will play a significant role not just in aiding patients but also in maintaining the wellbeing of physicians and healthcare staff in the case of an epidemic. The crises are changing views on what is feasible in terms of innovation and strategic intervention on the part of both private and policy players. When the COVID-19 pandemic is finished, the variety of technologies and industries are built into robotics. The virus was a successful chance for businesses to show robotics for public applications. One of the most common is the installation of mobile unmanned ultraviolet (UV) light platforms to disinfect facilities. Danish business UVD Robotics is taking advantage of this potential and is increasing the application of robotics to clean hospitals. The U.S. based Germ Falcon provides identical UV disinfection approaches for airplanes, while Chinese TMiRob deploys UV disinfection robots in Wuhan. "Automation of disinfection is a vital aspect of preserving health and safety and maybe one of the big bright points in reaction to COVID-19. In the near term, the policymakers would need to improve their defense apparatuses as well as the effectiveness of their medical services in order to implement quarantine mandates. The robots should be crucial to doing this by disinfection, tracking and surveillance. Throughout the long run, COVID-19 is contributing to a major reassessment of the worldwide supply chain in production. America's reliance on Chinese imports of essential machinery and drugs is becoming a controversial problem, and policy officials are now seeing the crisis as an incentive to revitalize the drive to re-launch more manufacturing resources on the domestic sector. Whether that turns into more drastic intervention by policymakers to diversify or re-land the output of key products, it may very well bode for the robotics sector, because these reforms will entail substantial rises in CAPEX and efficiency gains in developing countries. Instead of the infectivity of COVID-19, it is better if human-to-human interaction is minimal. Since robots are free for contamination, software companies such as JD.com and others have invested to get more robots marching down the main street to provide medical equipment in healthcare settings. The robots often end up becoming critical when providing vital items to individuals who order and purchase digitally and are lonely at home. Meituan Dianping, a logistics platform, is growing the 'contactless shipping' choices by automated vehicles and robots. Shenzhen-based company Pudu Technology aimed to reduce cross-infection by introducing a robotic home distribution of medications and food. COVID-19 poses a nightmare for robotic manufacturers designing applications for emerging economies in the automotive, construction and supply chain industries. But for vendors targeting markets which that are closer to government, such as safety, education, and protection, this is a great opportunity. Whitton advises that 'the market players create tailored solutions for non-manufacturing use cases or aim to create integrated solutions to allow scale-up in the manufacture of medical supplies. To mobile robotics manufacturers and tech firms pursuing more global markets, this is a perfect chance to demonstrate the role of healthcare robotics in solving national crises as well as alleviating economic shock.
What COVID-19 Impacted on Prenatal Testing & Newborn Screening in Healthcare Industry ?
Impact of COVID-19 on Prenatal Testing and Newborn Screening in Healthcare Industry OVERVIEW AFTERMATH OF COVID-19 AND GOVERNMENT ROLE A recent SARS-CoV-2, virus has caused a general pandemic of respiratory disease, called COVID-19. The infection initially showed up in Wuhan, a city in China, in December 2019. The patients experiencing COVID-19 are cautiously dealt with all the safety measures since this sickness spreads quicker through actual contact. There are now numerous vaccines in use. The first mass vaccination program commenced in early December 2020 and as of 15 February 2021, 175.3 million vaccine doses have been administered. World Health Organization (WHO) issued an Emergency Use Listing (EULs) for the Pfizer COVID-19 vaccine (BNT162b2) on 31 December 2020, issued another two EULs for two versions of the AstraZeneca/Oxford COVID-19 vaccine, manufactured by the Serum Institute of India and SKBio on 15 February 2021. On 12 March 2021, WHO issued a EUL for the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson) As per the WHO report, globally, as of 2 June 2021, there have been 170,812,850 confirmed cases of COVID-19, including 3,557,586 deaths, reported to WHO. As of 2 June 2021, a total of 1,581,509,628 vaccine doses have been administered. As per the WHO report, in the United States of America, from 3 January 2020 to 4:26pm CEST, 2 June 2021, there have been 32,942,677 confirmed cases of COVID-19 with 588,866 deaths, reported to WHO. As of 27 May 2021, a total of 294,270,594 vaccine doses have been administered. Even though immunization is found for COVID-19, safeguards incorporate incessant hand-wash, wearing a face veil, and keeping up social separating. The goal of new born screening is the pre-symptomatic detection of infants with congenital conditions so that treatment may be commenced at the earliest to prevent, or improve, the long-term In light of the fiery impacts of the infection, there are hypothetical dangers that the viral contamination could delay the prenatal testing and newborn screening as there have been limited visits to the hospitals and testing centers due to the lockdown imposed by the government in different countries. Newborn screening is a public health service done in every U.S. state. A cluster of health disorders that remains inconspicuous at birth is tested for every newborn. Every newborn is tested for a group of health disorders that aren't otherwise found at birth. With a simple blood test, doctors can check for rare genetic, hormone-related, and metabolic conditions that can cause serious health problems. Newborn screening lets doctors diagnose babies rapidly and commence treatment as soon as possible. STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS The key players engaged in global wound healing manufacturing are making improvements to keep the speed during COVID-19. They are taking every single choice cautiously to expand on a consistent schedule for the market. The manufacturers are likewise giving a great deal of consideration in improving inventive items that can be utilized for the attractive impacts. Organizations working in the minimally invasive gastrointestinal surgical systems market embrace a few systems, including joint effort, arrangements, association, and market development, to improve their business. These essential choices by the organizations must give huge occasions to the market players working in the minimally invasive gastrointestinal surgical systems market. For instance, · December 2017, Eone-Diagnomics Genome Center (EDGC), a Korean genetic analysis company, announced its decision to apply machine learning-based artificial intelligence (AI) technology to its non-invasive prenatal test (NIPT) NICE 0. In 2019, AI specialist FDNA and PerkinElmer Genomics partnered to launch Face2Gene Labs for newborn testing. This decision enabled the company to flourish further in the market and helps in revenue generation IMPACT ON DEMAND Since the pandemic, due to the lockdown situation, the economic growth of a country is declining day by day. And the manufacturing units for various items shut down due to the non-availability of manpower. There will be opportunities in the coming time for manufacturers of digital health technologies to position themselves for the COVID-19 recovery. When COVID-19 responses ease, there will be an excess of elective surgeries procedures in emergency clinics. The pre-appointment programs can help smooth out the planning, arrangement, and conveyance of the medical professionals and the doctors. For instance, · CVS is a type of diagnostic test performed between 10.5 to 13.5 weeks of pregnancy. The procedure involves obtaining a small tissue sample from the placenta by inserting a thin needle through the woman’s abdomen or using a small catheter inserted through the cervix by a doctor. The method used depends on the location of the baby and the placenta. · Another diagnostic test called amniocentesis is performed from 15 weeks of pregnancy onward. A thin needle is inserted through the woman’s abdomen into the amniotic sac to withdraw a small sample of fluid from around the developing baby in amniocentesis. Cloud-based stages have an extraordinary preferred position in permitting the clinician and their representatives to design cases distantly while travel and medical clinic access limitations are set up. With the careful plans and embeds chose early, embed providers and emergency clinics have the chance to enhance their stock and creation (on account of patient-explicit custom parts) to address the accumulation of cases once the circumstance permits effectively. IMPACT ON SUPPLY Because of the pertinacious COVID-19 lockdown, sanctions have been forced by administrations of different nations. These limitations and boundaries across the nation’s borders prompted a diminishing stockpile because of restricted materials and labor force, and the halting of assembly line. The supply chain units are taking stringent measures and risk mitigation protocols to provide the devices to the manufacturers to the customer. The presence of key market players for the development and launch of the prenatal testing and new born screening systems will increase the net sales and show a surplus growth in the market. Additionally, the manufacturers are also taking crucial steps to ensure the availability of raw materials by and also they have to look into the quality of products. But since the demand is increasing day by day, to meet the demand, the major manufacturers and suppliers collaborate to ensure the supply of raw materials. IMPACT ON PRICE Because of COVID-19, the market is upset to a major level. The few foundations need to stay shut while others to downsize the activities or put on pause extension plans as they attempted to endure the uncommon emergency. Now, as the demand for telehealth innovation is turning out to be very demanding by human being, and this will make the market more competitive due to new and more innovative equipment that will be launched by the makers, by decreasing the overall cost of the new and innovative prenatal testing & newborn screening systems and solutions. The current COVID-19 episode has influenced every industry on earth, and prenatal testing & newborn screening market is no exemption. There has been a tremendous and sudden lessening in the volume of elective joint substitutions worldwide as wellbeing situation legitimately organize their COVID-19 reaction. States must develop and implement policies that allow for interstate licensure and practice of medicine (entailing the use of telemedicine) to enable consultation and communication to remote areas and ensure the swift flow of information across state lines. CONCLUSION All three components (blood spot screening, hearing, and CCHD screening) of newborn screening are requisite for babies and should still occur during the COVID-19 pandemic. Babies with newborn screening conditions still need to undergo monitoring and treatment promptly for newborn screening conditions during the COVID-19 pandemic. State and territory newborn screening programs are still conducting the newborn screening. Babies should still receive newborn screening during the COVID-19 pandemic. Local manufacturers are now adapting new and better characteristics to create enormous supply measures to address the issue in coming fates and also the government is also helping to defeat all the difficulties faced in these unprecedented times. It is estimated that the COVID-19 pandemic outbreak has a negative impact on the growth of the global minimally invasive gastrointestinal surgical systems market. The growing prevalence of genetic diseases has necessitated a stable healthcare network and adequate emergency medical services (EMS). However, certain challenges in Research and Development and the loss of patent of the devices may hamper the market growth. The sales of prenatal testing and newborn screening tests services and related goods by entities (organizations, sole traders and partnerships) that offers prenatal testing and newborn screening tests, which aids in determining various genetic and chromosomal diseases, to furnish timely medical or surgical treatment of a condition before or after birth. Moreover, the wider adoption of these systems is expected to increase to meet the rising demand for prenatal testing and newborn screening across the globe and overcome the shortage of healthcare professionals to perform such testing and screening. In the wake of the pandemic, current industry players with a substantial market share that consumed cash-rich and good management teams would prosper. Making the correct actions would enable businesses to demonstrate preparation and offer end-users reliability
What COVID-19 Impacted on Artificial Blood Substitutes Market in Healthcare Industry ?
Impact of COVID-19 on Artificial Blood Substitutes Market in Healthcare Industry COVID-19 pandemic has influenced the whole planet with its major impacts on the economy and businesses across the globe. The COVID-19 spread worldwide in unprecedented ways due to its high infectious and contagious nature and lack of availability of its vaccine. As a result, the greatest medical challenge in the 21st century is yet to be faced by physicians worldwide. Though the emergence of the virus can be traced back to Asia, many European countries along with the U.S. have been struck massively by the pandemic. The virus has spread across all regions ranging from North America, Europe, Asia-Pacific, Middle East, and Africa up to South America. The COVID-19 has been declared as a pandemic by World Health Organization (WHO) due to its increased spread across the globe. After the declaration of the pandemic, various countries announced the complete lockdown such as India, China, and other Asian countries to decrease its spread. According to the latest situation report by World Health Organization (WHO) stated 175 million cases of the corona have been reported globally and 4 million patients are dead due to the coronavirus. On a slightly positive note, a total of 158 million people have recovered and total of 2 million vaccine doses have been administered as well. The COVID-19 has led to the lockdown all around the world which has impacted the artificial blood substitute market tremendously. Moreover, the coronavirus leads to a drop in oxygen in the body, and artificial blood substitute may be the solution for that as it offers high oxygen-carrying capacity in comparison to the human blood. Although, rising awareness regarding the toxicity and side effects of artificial blood substitutes coupled with the low number of FDA approval for artificial blood substitute products may hamper the growth of the market on a global level. The COVID-19 pandemic has affected the artificial blood substitute market positively on a global level. The persistence of COVID-19 for a longer period has affected the supply and demand chain of human blood and blood component. During the COVID-19 pandemic, manufacturers are expecting a boost in their market as the number of patients needing blood is also increasing with the ongoing diseases and the number of blood donor decreased. Due to this, the demand for artificial blood substitutes has increased which will propel the growth of the global artificial blood substitute market. IMPACT ON SUPPLY AND DEMAND With the ongoing pandemic, the government has put restrictions on the movement of citizens as well as industries, educational institutions, and social organizations. Due to which everything is closed across the country and majorly the blood donation camp are organized by these sectors but with the restriction on movement there is a hold on that. As there is no prior arrangement for blood donation which has worsened the supply of blood as people are not willing to visit blood centres for donation. For instance, · According to the International Society of Blood Transfusion, the survey has shown that blood donations have dropped in 32 countries, and the COVID-19 pandemic has reduced the overall supply of blood. With the limited supply of human blood, the demand for artificial blood substitutes has increased, which will boost the growth of the market even in the future. People suffering from a disease such as a thalassemia, sickle cell anaemia, haemophilia, leukaemia cancer, and other blood-related diseases need regular blood transfusion even during COVID-19 condition which has increased the demand for artificial blood substitute. Even cancer patients, obstetric conditions, victims of accidents need blood products. The supply chain disruption of blood has driven the demand for artificial blood substitutes across the globe. THE INCREASING DEMAND FOR BLOOD TRANSFUSION IS LEADING THE ARTIFICIAL BLOOD SUBSTITUTES MARKET. The demand for artificial blood is increasing for the blood transfusion process as it offers various advantages over human blood. The artificial blood could be stored for a longer period even for 3 years at room temperature whereas the human blood could only be stored for 42 days. Artificial blood also reduces the risk of contamination of other diseases such as hepatitis, AIDS, and others. One of the main factors driving the artificial blood substitute market is its high oxygen-carrying capacity as one of the major crises in COVID-19 patients is the drop in oxygen level, which could be recovered with artificial blood substitutes as it has high oxygen-carrying capacity in comparison to the human blood. The rising incidence of blood-related diseases increases the demand for blood transfusion and the shortage of blood during a pandemic will push the growth of the global artificial blood substitutes market. For instance, · According to Zee Entertainment Enterprises Limited, American Red Cross has seen a 10% rise in demand for red blood cells for hospital trauma centers as compared with the demand in 2019. The rising incidence of blood-related diseases and increase in the need for blood and blood transfusion will boost the market growth in the future. Also, the artificial blood substitute is preferred over the human blood as it is compatible with all blood types and can be given to the patients regardless of their blood type. Moreover, the vaccinated people are not donating blood which has affected the blood supply and will eventually boost the growth of artificial blood. For instance, · According to Cable News Network LP, LLLP, the regulations have been laid down that the vaccinated individual won’t be able to donate for at least 60 days, which could trigger a major shortage in the blood bank. · In May 2021, According to Science Wire, National Blood Transfusion Council (NBTC) has issued an order stating a person cannot donate blood 28 days post-vaccination, and people who received Covaxin have to wait for 56 days and who received Covishield, up to 70 days. The regulations for donating blood post-vaccination will affect the supply chain of blood and will lead to its increased demand and create a great opportunity for artificial blood substitutes. AFTERMATH OF COVID-19 The COVID-19 outbreak has impacted the healthcare system and has led to a decrease in the supply of blood. As coronavirus caused severe acute respiratory syndrome and due to which a lot of people died. The crucial staff members of the hospital also died during the pandemic and along with that, there is a reduction in the number of donations of blood and blood component. Therefore, with decreased blood donation the demand for blood has been increased to support ongoing critical needs and to treat a large number of patients. Hence, the professionals are looking out for options for instance artificial blood substitutes to treat patients on time. The COVID-19 pandemic has majorly affected the healthcare system and blood supply and demand across the globe. For instance, · According to World Health Organisation (WHO), a survey has been conducted in the African region which shows the impact of COVID-19 on blood supply and its demand, according to the data the total number of blood donations has dropped in 32 countries and rise in only 5 countries. Also, the proportion of blood drive has decreased in 21 countries. With the rising incidence of blood-related diseases, the demand for blood will be increased and due to the lack of availability of fresh blood, the need for artificial blood will be increased after the COVID-19 outbreak. The COVID-19 pandemic has led to the reduction of blood and blood-related activities, including demand and supply, and has affected the healthcare system on a major level. CONCLUSION Pandemic has taken a toll on every aspect of life, including the global economy. With the significant downfalls in many sectors, a collaborative effort of government, industry players, and consumers can win the fight against COVID-19. COVID-19 pandemic has affected the artificial blood substitute market positively. The demand for blood has increased immensely especially in the COVID-19 crisis as the number of patients needing blood has increased whereas the number of donors decreased. This factor will boost the growth of the market. During the COVID-19 outbreak, the government has posed a ban on movement due to which the blood donation camps could not be organized, which is the main reason that the supply of human blood has decreased. Although the demand for blood is much higher than the donation, it requires an alternate solution. The rising awareness regarding the advantages of artificial blood over human blood will propel market growth globally. Moreover, the incidence of blood-related diseases and the demand for blood transfusion has increased especially in COVID-19 time. Therefore, the need for artificial blood substitute which can be stored for a longer period and can be given to the patients irrespective of their blood type will drive the market growth even in the future. Therefore, the increasing prevalence of diseases will increase the demand for artificial blood substitutes and the market will grow even after the COVID-19 is over.
CBD for Sleep, CBD Benefits, Side Effects, and Treatment
People have long used the cannabis plant for medicinal and recreational purposes. Compounds called cannabinoids in the plant are responsible for the effects on the brain, and the two most abundant of these are tetrahydrocannabinol (THC) and cannabidiol (CBD). People use CBD for a variety of reasons, including reducing seizures, anxiety, and pain. Some studies have demonstrated that CBD may also be a sleep aid. In this article, we look at whether it works and any associated risks. What the research says In the last decade, growing public interest in the benefits of marijuana, and CBD in particular, has encouraged researchers to study its effects. Early studies indicate that high dosages of CBD may support sleep. One investigation found that, compared with a placebo, a CBD dosage of 160 milligrams (mg) increased sleep duration. The researchers also concluded that the placebo, 5 mg of the insomnia drug nitrazepam, and 40, 80, and 160 mg of CBD helped the participants fall asleep. The stress hormone levels of cortisol are typically peak in the morning, but people with insomnia may have high cortisol levels at night. Independent of insomnia, having high cortisol levels at night is associated with an increased nighttime awakening. In one study on the effects of CBD, researchers found that cortisol levels decreased more significantly when participants took 300 or 600 mg of CBD oil. These results suggest that CBD affects the release of cortisol, possibly acting as a sedative. A more recent analysis of CBD and sleep recruited 103 participants who had anxiety or poor sleep. The researchers studied the effects of CBD combined with those of other prescribed medications. The CBD dosages ranged from 25–175 mg. The researchers found that 25 mg was the most effective dosage for anxiety and that addressing troubled sleep required higher dosages. During the 3-month study, the investigators followed up with the participants monthly. At the first follow-up, 66.7% reported an improvement in sleep, but 25% had worsened sleep. 56.1% of the participants reported improved sleep at the second, but 26.8% had worsened sleep. The researchers conclude that although CBD might help people sleep in the short term, the effects may not be sustained. Side effects and other risks of CBD Overall, the available evidence suggests that CBD is well-tolerated. Some people report fatigue and mental sedation with CBD use, but researchers believe this may be related to the dosage. Taking 10–400 mg of CBD per day for an extended period and by different routes did not have a toxic effect on participants in a large retrospective study. Even dosages of up to 1,500 mg per day were well-tolerated, other researchers report. However, determining whether there are long-term risks of CBD use will require further studies. So far, no reports of lethal CBD overdoses exist. Some researchers may be concerned about CBD abuse, but information on significant complications is limited. One study indicates that dosages of 400–700 mg of CBD, which is considered high, can aggravate cognitive deficits in people with schizophrenia. Combining CBD and THC may, however, improve cognition. Researchers do report that CBD may cause other adverse effects, including: alterations of cell viability in studies conducted in cell cultures decreased fertilization capacity inhibition of drug metabolism in the liver reduced activity of P-glycoprotein and other drug transporters If these effects on drug metabolism and transportation are confirmed, it would indicate that CBD interferes with other medications. Overall, more research is necessary. Still, it is suitable for anyone who wants to use CBD to speak with a healthcare provider first. Check out the best CBD for sleep at Sweet Dream Beauty website.
6 Easy Ways To A Smooth Neck
Because the skin on your neck is some of the thinnest on your body, it is also one of the first places to show signs of ageing. Here are six ways to make your neck look younger and address everything from sun damage to sagging on this delicate area. 1. WEAR SUNSCREEN EVERY SINGLE DAY. Your dermatologist will agree that a nickel-sized amount of sunscreen applied to your neck and chest every day will help prevent collagen breakdown and the formation of sunspots. Don't forget to massage the sides and back of your neck. 2. MAINTAIN YOUR SKIN'S MOISTURIZATION. Again, the skin on your neck is thinner and has fewer oil glands than the rest of your body, so keeping the area hydrated is essential for a smoother overall texture. Look for peptide-containing creams (which can help stimulate new collagen growth) and apply them in gentle, upward strokes from your chest to your jawline. 3. RECLAIM YOUR BEAUTY SLEEP. Do you always wake up with pillow lines on the side of your neck? Apply one of these silicone patches before going to bed to keep your skin from crinkling while you sleep. You'll wake up with a smoother neck and less chance of further damage. 4. FOCUS ON CORRECT POSTURE. The amount of time we spend looking down at our phones and screens has resulted in what we now refer to as "tech neck." The simplest solution would be to limit screen time entirely, but more realistically, you should keep everything as close to eye level as possible to avoid unnecessary wrinkling. 5. GIVE LASER TREATMENTS A GO AHEAD. Still have fine lines on your neck? Fraxel lasers, stimulate your body's natural repair process to promote collagen growth. Fraxel can also be used to treat any dark spots or broken capillaries in the area, giving you a more even complexion. 6. ULTRASOUND TREATMENT FOR SERIOUS REPAIR. Ultherapy or Ultracel is your best non-surgical option for deeper, more stubborn lines and sagging. The FDA-approved treatment uses heat generated by focused sonic waves to penetrate deeper into the skin and stimulate the production of new collagen. Take note that the effect is gradual, and most patients notice a lifting effect three to six months after the initial treatment, so be patient.
Significant COVID-19 Impact on Nivolumab in Healthcare Industry
COVID-19 Impact on Nivolumab in Healthcare Industry COVID-19 (Coronavirus) has affected the day-to-day life of people and has slowed down the economies worldwide. The pandemic has affected millions of people who either got sick or died due to the spread of this disease. Within a few months, coronavirus disease (COVID-19), which originated from China, became a pandemic, with more than 30 million people being infected till date. There are now numerous vaccines in use. The first mass vaccination program commenced in early December 2020, and as of 15 February 2021, 175.3 million vaccine doses have been administered. There is an added complexity because of COVID-19 diagnosis in cancer patients, particularly while on active treatment with immunotherapy like nivolumab. COVID-19 could cause more harm to cancer patients. In order to prevent the infection from spreading, the patient’s number and new diagnosis have been less during the COVID 19. The COVID-19 pandemic has led to a dramatic loss of human life worldwide and presents an unprecedented challenge to public health, food systems, and the world of work. Still, there is an increase in the demand for cancer treatment with immunotherapy drugs like nivolumab during the second quarter of 2020 with the rise in awareness regarding health and new product launches in countries. IMPACT ON PRICE COVID-19 is significantly decreasing commercial activity in every area of the business sector. The economy has been decreased during the pandemic with the restricted and disrupted supply and sales of products and devices. The cost of medication and treatment of nivolumab has been increased due to the increasing demand for this drug during COVID-19. This contributed to the increased expenses and prices of immunotherapy drugs. Changes in the economy and other factors have caused consequences, including the decrease in the sales of the drug in some countries such as the U.S. With the rise of COVID-19 and decrease in new patients has also contributed to the increased cost and priced of some products and medication. · The price of Opdivo (nivolumab) drug which is a most common therapy treatment for various type of cancer or tumor have been increased to USD 1,172 for a supply of 4 milliliters of injection in 2020 with the rise in demand and increasing patients population in the second quarter of 2020. IMPACT ON DEMAND Global economic development in 2020 has been severely impacted by the COVID-19 pandemic. The COVID-19 has given rise to risks such as a prolonged, significant decline in global demand as well as unfavorable geopolitical and macroeconomic effects. The coronavirus pandemic has provoked many strategical actions among healthcare providers on how to manage cancer patients when faced with the threat of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infection. There has been a decrease in demand for nivolumab in some countries like the U.S., whereas many countries have seen an increase in sales with the rise in demand for the treatment and new cancer patients. With the rise in demand for the drug, FDA has provided approval to various drugs related to the immunotherapy nivolumab. For instance- · For the Bristol-Myers Squibb Company, the U.S. revenues of nivolumab decreased to 9% in 2020 due to lower demand caused by declining second-line eligibility across tumor indications and lower demand from COVID-19 (primarily lower new patient starts and patient visits). The U.S. has seen a decrease in sales in the first quarter of 2020. · However, the international revenues for nivolumab were increased up to 7% in 2020 due to higher demand as a result of additional indication launches in some countries with rising cancer patients globally. · In May 2021 -- Bristol-Myers Squibb Company has today announced that the U.S. Food and Drug Administration (FDA) had approved their Opdivo (nivolumab, injection for intravenous use) for the adjuvant treatment of completely resected esophageal or gastroesophageal junction (GEJ) cancer. · Similarly, FDA has approved Opdivo (nivolumab) for treating different types of cancer in many countries via various market players due to the rise in demand for this drug. IMPACT ON SUPPLY CHAIN The pandemic and COVID-19 have affected every business activity in which the supply chain was affected the most. Because of the pertinacious COVID-19 lockdown, sanctions have been forced by administrations of different nations. These limitations and boundaries across the nation’s borders prompted a diminishing stockpile because of restricted materials and labor force and the halting of the assembly line. The COVID-19 pandemic has transformed many organizations’ business environments; supply availability has been hampered by a number of issues, including export and travel restrictions by some producing countries, and the lockdown has forced suppliers to (temporarily) shut down. The supply of nivolumab medication has a slight decrease in sales during the first quarter of 2020, partly due to negative factors mentioned above in connection with the COVID-19 pandemic, which particularly didn’t affect the overall yearly revenue. The supply chain and demand were positively affected by the COVID 19. The sales and supply of the drugs have been increased with the rise in demand for the drugs and diagnosis. Many major manufacturing companies have launched their drugs in different countries to fulfill the demand, and the government has provided approval for the sales of the drug nivolumab. For instance- Despite the pandemic, many market player of nivolumab has increased their sales globally. This is due to the ongoing increase in the patient population and rising awareness regarding their health. · The sales of ONO pharmaceuticals have been increased in the year 2020 as compared to 2019, which is 2656.05 USD Million in 2019 and 2809.23 USD million. · Similarly, sales of the drug Opdivo (Nivolumab) from the manufacturing company Bristol Myers Squibb Company have been increased globally (except the U.S.) from USD 2,860 million in 2019 to USD 3,047 million in 2020. This increase in sales in both of the major market players is due to the increase in cancer patients and the use of drugs in all areas of cancer. There is an increase in the sales of this nivolumab with the rise in prevalence of disease and early diagnosis & treatment. STRATEGIC DECISIONS BY MANUFACTURERS To deal with the COVID-19 outbreak challenges and increasing demand for the drugs, many market players are creating new strategies such as new product development, telemedicine, and a different program to support patients and to raise their sales. It is predicted that these strategies are anticipated to escalate up the company revenue and its growth in the forecasted period. The government has provided drug FDA approvals of nivolumab for the treatment of cancer. For instance, · In May 2020, Bristol Myers Company announced that Opdivo (nivolumab) 3 mg/kg plus Yervoy (ipilimumab) 1 mg/kg (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with metastatic non-small cell lung cancer (NSCLC). · There are several ongoing potentially registrational studies that have been conducted by different manufacturing companies for Opdivo for the treatment of different tumor types and disease areas, in combination with various anti-cancer agents · Also, there are various ongoing clinical trials conducting on nivolumab with the combination of various anti-cancer agents and others to treat various types of cancer to decrease the demand for cancer treatment and to provide patients with more advanced drugs. For instance · In Japan, South Korea, and Taiwan, ONO pharmaceuticals are co-developing this drug nivolumab with the Bristol Myers Company CONCLUSION As the pandemic of COVID-19 resulted in several restrictions throughout the borders, still, manufacturers and market players were able to manage their sales and revenue of oncology and drug nivolumab. Various manufacturers allowed their workers to work in a clean and safe environment so as to boost up the production at various manufacturing facilities across several regions of the world, thus, helping them to maintain a continuous supply chain with the increasing demand. Market players have come up with better strategies which have also created a positive impact on the growth of the nivolumab market globally.